ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Salt Lake City, UT, USA:

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes (MODIUS)

of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type ...

Enrolling
Type 2 Diabetes (T2D)
Type 1 Diabetes (T1D)
Device: MODI Algorithm
DreaMed Diabetes

Sandy City, Utah, United States and 2 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Salt Lake City, Utah, United States and 27 other locations

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellit...

Enrolling
Type 2 Diabetes Mellitus
T2DM
Drug: HM15275
Drug: Placebo of HM15275

Phase 2

Hanmi Pharmaceutical
Hanmi Pharmaceutical

Salt Lake City, Utah, United States and 9 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Salt Lake City, Utah, United States of America and 24 other locations

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: KAI-9531
Drug: Placebo

Phase 3

Kailera

Salt Lake City, Utah, United States and 51 other locations

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....

Enrolling
Diabetes Mellitus, Type 1
Drug: Cadisegliatin 800 mg QD
Drug: Placebo

Phase 3

vTv Therapeutics
vTv Therapeutics

Salt Lake City, Utah, United States of America and 59 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle

Phase 3

Energenesis Biomedical

Salt Lake City, Utah, United States of America and 23 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

sandy, Utah, United States of America and 79 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Enrolling
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Salt Lake City, Utah, United States and 182 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Salt Lake City, Utah, United States and 29 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems